Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-046773
Filing Date
2021-12-03
Accepted
2021-12-03 16:17:53
Documents
1
Period of Report
2021-12-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4280
  Complete submission text file 0000899243-21-046773.txt   5633
Mailing Address 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121
Business Address
Gujrathi Sheila (Reporting) CIK: 0001575202 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40928 | Film No.: 211470255

Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations